» Articles » PMID: 15083781

Quality of Life in Patients with Psoriasis: a Systematic Literature Review

Overview
Publisher Elsevier
Specialty Dermatology
Date 2004 Apr 16
PMID 15083781
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Data on physical, psychological, and social functioning of patients with psoriasis have been presented in many studies. The introduction of quality-of-life questionnaires has made it possible to systematically compare these data across studies. The aim of this study was to present an overview of quality-of-life data and to describe the relationship between demographic and clinical variables and quality of life in patients with psoriasis. Computerized bibliographic databases were screened for publications from January 1966 to April 2000. Predefined selection criteria were used to identify quality-of-life studies in psoriasis. Two investigators independently assessed and, subsequently, agreed on inclusion. Data were extracted on the objectives, methods, sample characteristics, and results of the studies. A total of 118 publications were found. Seventeen studies met the inclusion criteria. Patients with psoriasis reported physical discomfort, impaired emotional functioning, a negative body and self-image, and limitations in daily activities, social contacts and (skin-exposing) activities, and work. More severe psoriasis was associated with lower levels of quality of life. There was a tendency that higher age was associated with slightly lower levels of physical functioning and slightly higher levels of psychological functioning and overall quality of life. Sex and quality of life were found to be unrelated.

Citing Articles

PSO-TARGET: a New Tool to Identify the Therapeutic Expectations of Psoriasis Patients Treated with Biologics.

Reguiai Z, Ghislain P, Moulin P, Baudier E, Schepkens C, Sintes M Dermatol Ther (Heidelb). 2025; 15(3):707-719.

PMID: 39979765 DOI: 10.1007/s13555-025-01356-8.


Patient Disease Characteristics and Treatment Patterns in Mild-Moderate Psoriasis: Results from Real-World Clinical Practice in the United States (PROSPECT Study).

Goddard E, Haughton J, Lucas J, Barlow S, Fitzgerald T, Litvintchouk A Dermatol Ther (Heidelb). 2025; 15(3):663-680.

PMID: 39961971 DOI: 10.1007/s13555-025-01353-x.


Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials.

Merola J, Gottlieb A, Pinter A, Elewski B, Gooderham M, Warren R Dermatol Ther (Heidelb). 2024; 14(12):3291-3306.

PMID: 39578348 PMC: 11604908. DOI: 10.1007/s13555-024-01295-w.


Quality of Life in Psoriasis: A Cross-Sectional Study from North India.

Arora K, Hazarika N, Kumari R, Chawla H Indian J Dermatol. 2024; 69(1):38-43.

PMID: 38572024 PMC: 10986881. DOI: 10.4103/ijd.ijd_144_23.


Exploring comorbidity and pharmacological treatment patterns in psoriasis - a retrospective population-based cross-sectional study.

Hamgard N, Duvetorp A, Hagg A, Jerkovic Gullin S, Seifert O J Multimorb Comorb. 2023; 13:26335565231212336.

PMID: 37915465 PMC: 10617277. DOI: 10.1177/26335565231212336.